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The purpose of the proposed study is to determine rapid effects of resveratrol, genistein, and daidzein on Rho GTPases and downstream effectors involved in breast cancer cell motility. The scope of the study is to determine signaling pathways affected by the phytoestrogens regarding cell motility and to use confocal microscopy to track in vivo the metastatic potential of cells treated with phytoestrogens in mice. To date, there are no major findings associated with this investigation because at the same time the PI was awarded this DOD fellowship, the PI was also awarded a NIH fellowship and chose to take the NIH award for research support. Dr. Katherine Moore advised the PI to keep the DOD award and transfer the support to a new graduate student in fall 2005. The PI has not initiated the proposed project nor has the PI used any of the funding. In September 2005, a new fellow will be named and the funding will be transferred (please see Appendix 1 for e-mail correspondence between Judy Pawlus and the PI).
No key accomplishments or reportable outcomes have been completed as the project was never initiated and has been put on hold until a new recipient is named. Introduction: Estrogen (17-beta-estradiol; E2) is a human female steroid hormone that plays critical roles in normal breast development as well as breast cancer formation. But its effects on breast cancer progression arc not well characterized. Non-genomic effects of E2 have been reported from a variety of cell types including breast cancer cells (1) . These rapid effects may bc significant in signaling to the actin cytoskeleton as well as proteins involved in cancer cell motility and migration.
Phytoestrogens are naturally occurring estrogen-like plant compounds which are known to act as agonists or antagonists of E2 and may have protective action against some cancers and prevent thc undesirable symptoms of menopause (2) . Most studies on phytoestrogen action in breast cancer have focused on their relevance in prevention of the onset of breast cancer, though some studies show that phytoestrogens also have effects on metastasis.
Gcnistcin and daidzcin (phytoestrogcns from soy) inhibited melanoma metastasis, intestinal adenocarcinoma, and prostrate carcinoma metastasis in mouse and rat models (3). I owever, most of these studies monitored long-term exposure of genistein and thus its effect on down-regulation of genes involved in invasion and angiogenesis (4) . Other studies actually demonstrate increased tumor growth and lung metastasis upon administration of soybean extracts (5) . T1he in vivo actions of genistein may therefore extend beyond those traditionally implicated in chemoprevention like antiproliferation. T1hus, genistein may act in vivo by blocking additional stages of breast cancer progression such as those stages resulting in invasion and metastasis (6) .
Resveratrol (a phytoestrogen from grapes/red wine) has been demonstrated to reduce hepatoma cell invasion and metastasis in vitro as well as in mice with hepatoma and Lewis lung carcinoma tumors (7). Recently, resveratrol was shown to affect actin cytoskeletal organization and inhibit invasion of ERcz[• (+) primary human breast cancer cell line MCF-7 (8) and in ERa (-) f3 (+I) MDA-MB-23 1 (9)
The members of Rho family of small GTPases are examples of potential key regulators of the initial steps of cancer metastasis. Rho GTPases are directly implicated in the regulation of the actin cytoskclcton and focal adhesion turnover during directed cell motility of invading cancer cells and contribute to metastasis (10).
Body:
The purpose of the proposed study is to determine rapid effects of resveratrol, genistein, and daidzein on Rho GTPases and downstream effectors involved in breast cancer cell motility. The scope of the study is to determine signaling pathways affected by the phytoestrogens regarding cell motility and to use confocal microscopy to track in vivo the metastatic potential of cells treated with phytoestrogens in mice.
To date, there are no major findings associated with this investigation because at the same time the Pl was awarded this DOD fellowship, the PT was also awarded a NTH fellowship and chose to take the NiII award for research support. Dr. Katherine Moore advised the P1 to keep the DOD award and transfer the support to a new graduate student in fall 2005. The PT has not initiated the proposed project nor has the PT used any of the funding. In September 2005, a new fellow will be named and the funding will be transferred (please see Appendix 1 for e-mail correspondence between Judy Pawlus and the t'I).
Key research accomplishments:
No key accomplishments have been completed as the project was never initiated and has been put on hold until a new recipient is named.
Reportable outcomes:
No reportable outcomes have been completed as the project was never initiated and has been put on hold until a new recipient is named.
Conclusions:
To date, there are no conclusions because the project was never initiated and has been put on hold until a new recipient is named. 
